Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Free Trade Agreements Not Useful Against Price Controls – Commerce Official

Executive Summary

The Commerce Department does not view free trade agreements as an effective tool to change international pharmaceutical price controls

You may also be interested in...



Canadian Import Growth Outpaces U.S. Rx Market In 2004, IMS Data Show

Canadian imports are still gaining share in the U.S. market despite the launch of multiple discount programs for seniors and other uninsured consumers, IMS Health data indicate

Canadian Import Growth Outpaces U.S. Rx Market In 2004, IMS Data Show

Canadian imports are still gaining share in the U.S. market despite the launch of multiple discount programs for seniors and other uninsured consumers, IMS Health data indicate

Reimportation Bill From Dorgan/Snowe Includes User Fees To Fund Oversight

A reimportation bill reintroduced by Sens. Byron Dorgan (D-N.D.) and Olympia Snowe (R-Maine) includes user fees for importers and foreign exporters to fund FDA's safety oversight

Related Content

Topics

UsernamePublicRestriction

Register

PS045405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel